Amundi 13F: Adds $407M to Astera Labs (ALAB) Stake
Amundi increased its holdings in Astera Labs, Inc. during the quarter, filing its latest position update with the SEC.
Reviewed by automated data checks against the source filing. How we make and check alerts
Amundi added 823,477 shares to its stake in Astera Labs, Inc. ($ALAB), a 77.88% increase, according to a 13F filing with the SEC dated May 18, 2026. It reported 1,880,830 shares worth $929.88 million at the end of the quarter.
Since the filing, $ALAB is up 47.8% after 1 week, up 73.8% after 1 month and up 32.6% to date (from the $215.58 close on May 18, 2026).
Key Points
- Amundi boosted its stake in Astera Labs, Inc. (NasdaqGS: ALAB) by 77.8% during the period, picking up 823,477 shares to bring its total holding to 1,880,830 shares valued at roughly $929.8 million.
- The semiconductor connectivity stock trades near $494.40, reflecting strong momentum as it sits close to its 52-week peak of $499.48.
- Recent analyst updates include Northland Capital Markets upgrading the stock to an outperform rating on August 17, 2026, alongside new price targets from several major firms.
Get $ALAB trade alerts by text
We text you when insiders, Congress or big funds trade $ALAB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Astera Labs, Inc. alert may contain errors. Disclosures
Amundi Expands Holding in Astera Labs
Amundi significantly grew its investment in Astera Labs, Inc. (NasdaqGS: ALAB) during the reporting period, according to a Form 13F filing with the Securities and Exchange Commission. The firm added 823,477 shares to its portfolio, marking a 77.8% increase from the prior quarter. That brought Amundi's total ownership to 1,880,830 shares. Based on the filing data, the stake was valued at approximately $929.8 million at the close of the period.
Astera Labs Stock Trades Near Peak
Shares of Astera Labs traded at $494.40 on Friday, placing the semiconductor developer close to its 52-week high of $499.48. The company has seen a strong run over the past year, far outpacing its 52-week low of $97.89. Because 13F disclosures look backward at positions held at the end of the quarter, the reported share count may not reflect the fund's exact holdings today.
Insider Buying and Selling at Astera Labs, Inc.
In insider transactions, Bethany Mayer sold 686 shares on June 24, 2026. The shares were disposed of at an average price of $395.04, totaling $270,998.67. This transaction was carried out under a pre-arranged Rule 10b5-1 trading plan.
Analysts Set New Price Targets
Wall Street firms have continued to adjust their outlooks on the semiconductor firm following recent operational updates. On August 17, 2026, Northland Capital Markets upgraded the stock to an outperform rating with a $350.00 price target. Earlier in the month on August 5, 2026, TD Cowen maintained its hold rating and lowered its price target to $375.00 from $425.00. On the same day, Morgan Stanley kept an overweight rating while lifting its target to $382.00 from $335.00, and RBC Capital maintained an outperform rating while raising its target to $500.00 from $425.00. Evercore ISI Group kept its outperform rating while lifting its target to $452.00 from $297.00, Needham maintained a buy rating with a raised target of $425.00, and Jefferies kept a buy rating with a target of $450.00. Later, on July 31, 2026, Susquehanna maintained a neutral rating while bumping its target to $275.00 from $230.00.
About Astera Labs
Astera Labs, Inc. designs specialized semiconductor connectivity solutions designed to support cloud and artificial intelligence infrastructure. Headquartered in San Jose, California, the company builds high-speed mixed-signal products, custom software suites, and specialized cable modules utilized by major data center operators and system builders.
What to Watch at Astera Labs, Inc.
Investors tracking Astera Labs will want to look out for subsequent 13F filings from other major institutional players to see how large asset managers are positioning themselves. The company's next scheduled earnings report is anticipated around November 3, 2026. Institutional filing data remains historical by nature and is only one piece of a broader portfolio puzzle.
Source: Amundi's 13F filing on $ALAB (May 18, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Amundi 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
